0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Medical Alpha Radionuclide Market Research Report 2026
Published Date: 2026-04-10
|
Report Code: QYRE-Auto-21U17036
Home | Market Reports | Health| Health Conditions| Cancer
Global Medical Alpha Radionuclide Market Research Report 2024
BUY CHAPTERS

Global Medical Alpha Radionuclide Market Research Report 2026

Code: QYRE-Auto-21U17036
Report
2026-04-10
Pages:141
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Medical Alpha Radionuclide Market Size

The global Medical Alpha Radionuclide market was valued at US$ 4010 million in 2025 and is anticipated to reach US$ 10280 million by 2032, at a CAGR of 14.6% from 2026 to 2032.

Medical Alpha Radionuclide Market

Medical Alpha Radionuclide Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Medical Alpha Radionuclide competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. It has the potential to provide highly targeted treatment, especially to microscopic tumour cells. Targets include leukemias, lymphomas, gliomas, melanoma, and peritoneal carcinomatosis. As in diagnostic nuclear medicine, appropriate radionuclides can be chemically bound to a targeting biomolecule which carries the combined radiopharmaceutical to a specific treatment point.
The North American market for Medical Alpha Radionuclide is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Medical Alpha Radionuclide is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Medical Alpha Radionuclide include ORNL, Tri-Lab, SSC RF-IPPE, JRC Karlsruhe, TerraPower, TRIUMF, Eckert&Ziegler, Ionetix, Orano Med, National Nuclear Laboratory, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Medical Alpha Radionuclide market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Medical Alpha Radionuclide. The Medical Alpha Radionuclide market size, estimates, and forecasts are provided in terms of shipments (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Medical Alpha Radionuclide market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Medical Alpha Radionuclide manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Medical Alpha Radionuclide Market Report

Report Metric Details
Report Name Medical Alpha Radionuclide Market
Accounted market size in 2025 US$ 4010 million
Forecasted market size in 2032 US$ 10280 million
CAGR 14.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Actinium-225
  • Astatine-211
  • Lead-212
  • Bismuth-213
  • Others
by Application
  • Immunotherapy
  • Peritoneal Carcinomas
  • Bone Metastases
  • Leukaemia
  • Melanomas
  • Solid Tumours
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company ORNL, Tri-Lab, SSC RF-IPPE, JRC Karlsruhe, TerraPower, TRIUMF, Eckert&Ziegler, Ionetix, Orano Med, National Nuclear Laboratory, NorthStar
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Medical Alpha Radionuclide manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
  • Chapter 3: Examines Medical Alpha Radionuclide production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
  • Chapter 4: Analyzes Medical Alpha Radionuclide consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
  • Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Medical Alpha Radionuclide Market growing?

Ans: The Medical Alpha Radionuclide Market witnessing a CAGR of 14.6% during the forecast period 2026-2032.

What is the Medical Alpha Radionuclide Market size in 2032?

Ans: The Medical Alpha Radionuclide Market size in 2032 will be US$ 10280 million.

Who are the main players in the Medical Alpha Radionuclide Market report?

Ans: The main players in the Medical Alpha Radionuclide Market are ORNL, Tri-Lab, SSC RF-IPPE, JRC Karlsruhe, TerraPower, TRIUMF, Eckert&Ziegler, Ionetix, Orano Med, National Nuclear Laboratory, NorthStar

What are the Application segmentation covered in the Medical Alpha Radionuclide Market report?

Ans: The Applications covered in the Medical Alpha Radionuclide Market report are Immunotherapy, Peritoneal Carcinomas, Bone Metastases, Leukaemia, Melanomas, Solid Tumours

What are the Type segmentation covered in the Medical Alpha Radionuclide Market report?

Ans: The Types covered in the Medical Alpha Radionuclide Market report are Actinium-225, Astatine-211, Lead-212, Bismuth-213, Others

1 Medical Alpha Radionuclide Market Overview
1.1 Product Definition
1.2 Medical Alpha Radionuclide by Type
1.2.1 Global Medical Alpha Radionuclide Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Actinium-225
1.2.3 Astatine-211
1.2.4 Lead-212
1.2.5 Bismuth-213
1.2.6 Others
1.3 Medical Alpha Radionuclide by Application
1.3.1 Global Medical Alpha Radionuclide Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Immunotherapy
1.3.3 Peritoneal Carcinomas
1.3.4 Bone Metastases
1.3.5 Leukaemia
1.3.6 Melanomas
1.3.7 Solid Tumours
1.4 Global Market Growth Prospects
1.4.1 Global Medical Alpha Radionuclide Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Medical Alpha Radionuclide Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Medical Alpha Radionuclide Production Estimates and Forecasts (2021–2032)
1.4.4 Global Medical Alpha Radionuclide Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Medical Alpha Radionuclide Production Market Share by Manufacturers (2021–2026)
2.2 Global Medical Alpha Radionuclide Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Medical Alpha Radionuclide, Industry Ranking, 2024 vs 2025
2.4 Global Medical Alpha Radionuclide Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Medical Alpha Radionuclide Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Medical Alpha Radionuclide, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Medical Alpha Radionuclide, Product Offerings and Applications
2.8 Global Key Manufacturers of Medical Alpha Radionuclide, Date of Entry into the Industry
2.9 Medical Alpha Radionuclide Market Competitive Situation and Trends
2.9.1 Medical Alpha Radionuclide Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Medical Alpha Radionuclide Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Medical Alpha Radionuclide Production by Region
3.1 Global Medical Alpha Radionuclide Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Medical Alpha Radionuclide Production Value by Region (2021–2032)
3.2.1 Global Medical Alpha Radionuclide Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Medical Alpha Radionuclide by Region (2027–2032)
3.3 Global Medical Alpha Radionuclide Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Medical Alpha Radionuclide Production Volume by Region (2021–2032)
3.4.1 Global Medical Alpha Radionuclide Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Medical Alpha Radionuclide by Region (2027–2032)
3.5 Global Medical Alpha Radionuclide Market Price Analysis by Region (2021–2026)
3.6 Global Medical Alpha Radionuclide Production, Value, and Year-over-Year Growth
3.6.1 North America Medical Alpha Radionuclide Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Medical Alpha Radionuclide Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Medical Alpha Radionuclide Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Medical Alpha Radionuclide Production Value Estimates and Forecasts (2021–2032)
4 Medical Alpha Radionuclide Consumption by Region
4.1 Global Medical Alpha Radionuclide Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Medical Alpha Radionuclide Consumption by Region (2021–2032)
4.2.1 Global Medical Alpha Radionuclide Consumption by Region (2021–2026)
4.2.2 Global Medical Alpha Radionuclide Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Medical Alpha Radionuclide Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Medical Alpha Radionuclide Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Medical Alpha Radionuclide Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Medical Alpha Radionuclide Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Medical Alpha Radionuclide Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Medical Alpha Radionuclide Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Medical Alpha Radionuclide Production by Type (2021–2032)
5.1.1 Global Medical Alpha Radionuclide Production by Type (2021–2026)
5.1.2 Global Medical Alpha Radionuclide Production by Type (2027–2032)
5.1.3 Global Medical Alpha Radionuclide Production Market Share by Type (2021–2032)
5.2 Global Medical Alpha Radionuclide Production Value by Type (2021–2032)
5.2.1 Global Medical Alpha Radionuclide Production Value by Type (2021–2026)
5.2.2 Global Medical Alpha Radionuclide Production Value by Type (2027–2032)
5.2.3 Global Medical Alpha Radionuclide Production Value Market Share by Type (2021–2032)
5.3 Global Medical Alpha Radionuclide Price by Type (2021–2032)
6 Segment by Application
6.1 Global Medical Alpha Radionuclide Production by Application (2021–2032)
6.1.1 Global Medical Alpha Radionuclide Production by Application (2021–2026)
6.1.2 Global Medical Alpha Radionuclide Production by Application (2027–2032)
6.1.3 Global Medical Alpha Radionuclide Production Market Share by Application (2021–2032)
6.2 Global Medical Alpha Radionuclide Production Value by Application (2021–2032)
6.2.1 Global Medical Alpha Radionuclide Production Value by Application (2021–2026)
6.2.2 Global Medical Alpha Radionuclide Production Value by Application (2027–2032)
6.2.3 Global Medical Alpha Radionuclide Production Value Market Share by Application (2021–2032)
6.3 Global Medical Alpha Radionuclide Price by Application (2021–2032)
7 Key Companies Profiled
7.1 ORNL
7.1.1 ORNL Medical Alpha Radionuclide Company Information
7.1.2 ORNL Medical Alpha Radionuclide Product Portfolio
7.1.3 ORNL Medical Alpha Radionuclide Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 ORNL Main Business and Markets Served
7.1.5 ORNL Recent Developments/Updates
7.2 Tri-Lab
7.2.1 Tri-Lab Medical Alpha Radionuclide Company Information
7.2.2 Tri-Lab Medical Alpha Radionuclide Product Portfolio
7.2.3 Tri-Lab Medical Alpha Radionuclide Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Tri-Lab Main Business and Markets Served
7.2.5 Tri-Lab Recent Developments/Updates
7.3 SSC RF-IPPE
7.3.1 SSC RF-IPPE Medical Alpha Radionuclide Company Information
7.3.2 SSC RF-IPPE Medical Alpha Radionuclide Product Portfolio
7.3.3 SSC RF-IPPE Medical Alpha Radionuclide Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 SSC RF-IPPE Main Business and Markets Served
7.3.5 SSC RF-IPPE Recent Developments/Updates
7.4 JRC Karlsruhe
7.4.1 JRC Karlsruhe Medical Alpha Radionuclide Company Information
7.4.2 JRC Karlsruhe Medical Alpha Radionuclide Product Portfolio
7.4.3 JRC Karlsruhe Medical Alpha Radionuclide Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 JRC Karlsruhe Main Business and Markets Served
7.4.5 JRC Karlsruhe Recent Developments/Updates
7.5 TerraPower
7.5.1 TerraPower Medical Alpha Radionuclide Company Information
7.5.2 TerraPower Medical Alpha Radionuclide Product Portfolio
7.5.3 TerraPower Medical Alpha Radionuclide Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 TerraPower Main Business and Markets Served
7.5.5 TerraPower Recent Developments/Updates
7.6 TRIUMF
7.6.1 TRIUMF Medical Alpha Radionuclide Company Information
7.6.2 TRIUMF Medical Alpha Radionuclide Product Portfolio
7.6.3 TRIUMF Medical Alpha Radionuclide Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 TRIUMF Main Business and Markets Served
7.6.5 TRIUMF Recent Developments/Updates
7.7 Eckert&Ziegler
7.7.1 Eckert&Ziegler Medical Alpha Radionuclide Company Information
7.7.2 Eckert&Ziegler Medical Alpha Radionuclide Product Portfolio
7.7.3 Eckert&Ziegler Medical Alpha Radionuclide Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Eckert&Ziegler Main Business and Markets Served
7.7.5 Eckert&Ziegler Recent Developments/Updates
7.8 Ionetix
7.8.1 Ionetix Medical Alpha Radionuclide Company Information
7.8.2 Ionetix Medical Alpha Radionuclide Product Portfolio
7.8.3 Ionetix Medical Alpha Radionuclide Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Ionetix Main Business and Markets Served
7.8.5 Ionetix Recent Developments/Updates
7.9 Orano Med
7.9.1 Orano Med Medical Alpha Radionuclide Company Information
7.9.2 Orano Med Medical Alpha Radionuclide Product Portfolio
7.9.3 Orano Med Medical Alpha Radionuclide Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Orano Med Main Business and Markets Served
7.9.5 Orano Med Recent Developments/Updates
7.10 National Nuclear Laboratory
7.10.1 National Nuclear Laboratory Medical Alpha Radionuclide Company Information
7.10.2 National Nuclear Laboratory Medical Alpha Radionuclide Product Portfolio
7.10.3 National Nuclear Laboratory Medical Alpha Radionuclide Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 National Nuclear Laboratory Main Business and Markets Served
7.10.5 National Nuclear Laboratory Recent Developments/Updates
7.11 NorthStar
7.11.1 NorthStar Medical Alpha Radionuclide Company Information
7.11.2 NorthStar Medical Alpha Radionuclide Product Portfolio
7.11.3 NorthStar Medical Alpha Radionuclide Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 NorthStar Main Business and Markets Served
7.11.5 NorthStar Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Medical Alpha Radionuclide Industry Chain Analysis
8.2 Medical Alpha Radionuclide Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Medical Alpha Radionuclide Production Modes and Processes
8.4 Medical Alpha Radionuclide Sales and Marketing
8.4.1 Medical Alpha Radionuclide Sales Channels
8.4.2 Medical Alpha Radionuclide Distributors
8.5 Medical Alpha Radionuclide Customer Analysis
9 Medical Alpha Radionuclide Market Dynamics
9.1 Medical Alpha Radionuclide Industry Trends
9.2 Medical Alpha Radionuclide Market Drivers
9.3 Medical Alpha Radionuclide Market Challenges
9.4 Medical Alpha Radionuclide Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Medical Alpha Radionuclide Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Medical Alpha Radionuclide Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Medical Alpha Radionuclide Production Capacity (kg) by Manufacturers in 2025
 Table 4. Global Medical Alpha Radionuclide Production by Manufacturers (kg), 2021–2026
 Table 5. Global Medical Alpha Radionuclide Production Market Share by Manufacturers (2021–2026)
 Table 6. Global Medical Alpha Radionuclide Production Value by Manufacturers (US$ Million), 2021–2026
 Table 7. Global Medical Alpha Radionuclide Production Value Share by Manufacturers (2021–2026)
 Table 8. Global Key Players of Medical Alpha Radionuclide, Industry Ranking, 2024 vs 2025
 Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Medical Alpha Radionuclide Production Value, 2025
 Table 10. Global Market Medical Alpha Radionuclide Average Price by Manufacturers (US$/g), 2021–2026
 Table 11. Global Key Manufacturers of Medical Alpha Radionuclide, Manufacturing Footprints and Headquarters
 Table 12. Global Key Manufacturers of Medical Alpha Radionuclide, Product Offerings and Applications
 Table 13. Global Key Manufacturers of Medical Alpha Radionuclide, Date of Entry into the Industry
 Table 14. Global Medical Alpha Radionuclide Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Medical Alpha Radionuclide Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Medical Alpha Radionuclide Production Value (US$ Million) by Region (2021–2026)
 Table 18. Global Medical Alpha Radionuclide Production Value Market Share by Region (2021–2026)
 Table 19. Global Medical Alpha Radionuclide Production Value (US$ Million) Forecast by Region (2027–2032)
 Table 20. Global Medical Alpha Radionuclide Production Value Market Share Forecast by Region (2027–2032)
 Table 21. Global Medical Alpha Radionuclide Production Comparison by Region: 2021 vs 2025 vs 2032 (kg)
 Table 22. Global Medical Alpha Radionuclide Production (kg) by Region (2021–2026)
 Table 23. Global Medical Alpha Radionuclide Production Market Share by Region (2021–2026)
 Table 24. Global Medical Alpha Radionuclide Production (kg) Forecast by Region (2027–2032)
 Table 25. Global Medical Alpha Radionuclide Production Market Share Forecast by Region (2027–2032)
 Table 26. Global Medical Alpha Radionuclide Market Average Price (US$/g) by Region (2021–2026)
 Table 27. Global Medical Alpha Radionuclide Market Average Price (US$/g) by Region (2027–2032)
 Table 28. Global Medical Alpha Radionuclide Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (kg)
 Table 29. Global Medical Alpha Radionuclide Consumption by Region (kg), 2021–2026
 Table 30. Global Medical Alpha Radionuclide Consumption Market Share by Region (2021–2026)
 Table 31. Global Medical Alpha Radionuclide Forecasted Consumption by Region (kg), 2027–2032
 Table 32. Global Medical Alpha Radionuclide Forecasted Consumption Market Share by Region (2027–2032)
 Table 33. North America Medical Alpha Radionuclide Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)
 Table 34. North America Medical Alpha Radionuclide Consumption by Country (kg), 2021–2026
 Table 35. North America Medical Alpha Radionuclide Consumption by Country (kg), 2027–2032
 Table 36. Europe Medical Alpha Radionuclide Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)
 Table 37. Europe Medical Alpha Radionuclide Consumption by Country (kg), 2021–2026
 Table 38. Europe Medical Alpha Radionuclide Consumption by Country (kg), 2027–2032
 Table 39. Asia Pacific Medical Alpha Radionuclide Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (kg)
 Table 40. Asia Pacific Medical Alpha Radionuclide Consumption by Region (kg), 2021–2026
 Table 41. Asia Pacific Medical Alpha Radionuclide Consumption by Region (kg), 2027–2032
 Table 42. Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (kg)
 Table 43. Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption by Country (kg), 2021–2026
 Table 44. Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption by Country (kg), 2027–2032
 Table 45. Global Medical Alpha Radionuclide Production (kg) by Type (2021–2026)
 Table 46. Global Medical Alpha Radionuclide Production (kg) by Type (2027–2032)
 Table 47. Global Medical Alpha Radionuclide Production Market Share by Type (2021–2026)
 Table 48. Global Medical Alpha Radionuclide Production Market Share by Type (2027–2032)
 Table 49. Global Medical Alpha Radionuclide Production Value (US$ Million) by Type (2021–2026)
 Table 50. Global Medical Alpha Radionuclide Production Value (US$ Million) by Type (2027–2032)
 Table 51. Global Medical Alpha Radionuclide Production Value Market Share by Type (2021–2026)
 Table 52. Global Medical Alpha Radionuclide Production Value Market Share by Type (2027–2032)
 Table 53. Global Medical Alpha Radionuclide Price (US$/g) by Type (2021–2026)
 Table 54. Global Medical Alpha Radionuclide Price (US$/g) by Type (2027–2032)
 Table 55. Global Medical Alpha Radionuclide Production (kg) by Application (2021–2026)
 Table 56. Global Medical Alpha Radionuclide Production (kg) by Application (2027–2032)
 Table 57. Global Medical Alpha Radionuclide Production Market Share by Application (2021–2026)
 Table 58. Global Medical Alpha Radionuclide Production Market Share by Application (2027–2032)
 Table 59. Global Medical Alpha Radionuclide Production Value (US$ Million) by Application (2021–2026)
 Table 60. Global Medical Alpha Radionuclide Production Value (US$ Million) by Application (2027–2032)
 Table 61. Global Medical Alpha Radionuclide Production Value Market Share by Application (2021–2026)
 Table 62. Global Medical Alpha Radionuclide Production Value Market Share by Application (2027–2032)
 Table 63. Global Medical Alpha Radionuclide Price (US$/g) by Application (2021–2026)
 Table 64. Global Medical Alpha Radionuclide Price (US$/g) by Application (2027–2032)
 Table 65. ORNL Medical Alpha Radionuclide Company Information
 Table 66. ORNL Medical Alpha Radionuclide Specification and Application
 Table 67. ORNL Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 68. ORNL Main Business and Markets Served
 Table 69. ORNL Recent Developments/Updates
 Table 70. Tri-Lab Medical Alpha Radionuclide Company Information
 Table 71. Tri-Lab Medical Alpha Radionuclide Specification and Application
 Table 72. Tri-Lab Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 73. Tri-Lab Main Business and Markets Served
 Table 74. Tri-Lab Recent Developments/Updates
 Table 75. SSC RF-IPPE Medical Alpha Radionuclide Company Information
 Table 76. SSC RF-IPPE Medical Alpha Radionuclide Specification and Application
 Table 77. SSC RF-IPPE Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 78. SSC RF-IPPE Main Business and Markets Served
 Table 79. SSC RF-IPPE Recent Developments/Updates
 Table 80. JRC Karlsruhe Medical Alpha Radionuclide Company Information
 Table 81. JRC Karlsruhe Medical Alpha Radionuclide Specification and Application
 Table 82. JRC Karlsruhe Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 83. JRC Karlsruhe Main Business and Markets Served
 Table 84. JRC Karlsruhe Recent Developments/Updates
 Table 85. TerraPower Medical Alpha Radionuclide Company Information
 Table 86. TerraPower Medical Alpha Radionuclide Specification and Application
 Table 87. TerraPower Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 88. TerraPower Main Business and Markets Served
 Table 89. TerraPower Recent Developments/Updates
 Table 90. TRIUMF Medical Alpha Radionuclide Company Information
 Table 91. TRIUMF Medical Alpha Radionuclide Specification and Application
 Table 92. TRIUMF Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 93. TRIUMF Main Business and Markets Served
 Table 94. TRIUMF Recent Developments/Updates
 Table 95. Eckert&Ziegler Medical Alpha Radionuclide Company Information
 Table 96. Eckert&Ziegler Medical Alpha Radionuclide Specification and Application
 Table 97. Eckert&Ziegler Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 98. Eckert&Ziegler Main Business and Markets Served
 Table 99. Eckert&Ziegler Recent Developments/Updates
 Table 100. Ionetix Medical Alpha Radionuclide Company Information
 Table 101. Ionetix Medical Alpha Radionuclide Specification and Application
 Table 102. Ionetix Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 103. Ionetix Main Business and Markets Served
 Table 104. Ionetix Recent Developments/Updates
 Table 105. Orano Med Medical Alpha Radionuclide Company Information
 Table 106. Orano Med Medical Alpha Radionuclide Specification and Application
 Table 107. Orano Med Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 108. Orano Med Main Business and Markets Served
 Table 109. Orano Med Recent Developments/Updates
 Table 110. National Nuclear Laboratory Medical Alpha Radionuclide Company Information
 Table 111. National Nuclear Laboratory Medical Alpha Radionuclide Specification and Application
 Table 112. National Nuclear Laboratory Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 113. National Nuclear Laboratory Main Business and Markets Served
 Table 114. National Nuclear Laboratory Recent Developments/Updates
 Table 115. NorthStar Medical Alpha Radionuclide Company Information
 Table 116. NorthStar Medical Alpha Radionuclide Specification and Application
 Table 117. NorthStar Medical Alpha Radionuclide Production (kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
 Table 118. NorthStar Main Business and Markets Served
 Table 119. NorthStar Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Medical Alpha Radionuclide Distributors List
 Table 123. Medical Alpha Radionuclide Customers List
 Table 124. Medical Alpha Radionuclide Market Trends
 Table 125. Medical Alpha Radionuclide Market Drivers
 Table 126. Medical Alpha Radionuclide Market Challenges
 Table 127. Medical Alpha Radionuclide Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Medical Alpha Radionuclide
 Figure 2. Global Medical Alpha Radionuclide Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Medical Alpha Radionuclide Market Share by Type: 2025 vs 2032
 Figure 4. Actinium-225 Product Picture
 Figure 5. Astatine-211 Product Picture
 Figure 6. Lead-212 Product Picture
 Figure 7. Bismuth-213 Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Medical Alpha Radionuclide Market Value by Application (US$ Million), 2021–2032
 Figure 10. Global Medical Alpha Radionuclide Market Share by Application: 2025 vs 2032
 Figure 11. Immunotherapy
 Figure 12. Peritoneal Carcinomas
 Figure 13. Bone Metastases
 Figure 14. Leukaemia
 Figure 15. Melanomas
 Figure 16. Solid Tumours
 Figure 17. Global Medical Alpha Radionuclide Production Value (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global Medical Alpha Radionuclide Production Value (US$ Million), 2021–2032
 Figure 19. Global Medical Alpha Radionuclide Production Capacity (kg), 2021–2032
 Figure 20. Global Medical Alpha Radionuclide Production (kg), 2021–2032
 Figure 21. Global Medical Alpha Radionuclide Average Price (US$/g), 2021–2032
 Figure 22. Medical Alpha Radionuclide Report Years Considered
 Figure 23. Medical Alpha Radionuclide Production Share by Manufacturers in 2025
 Figure 24. Global Medical Alpha Radionuclide Production Value Share by Manufacturers (2025)
 Figure 25. Medical Alpha Radionuclide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 26. Top 5 and Top 10 Global Players: Market Share by Medical Alpha Radionuclide Revenue in 2025
 Figure 27. Global Medical Alpha Radionuclide Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Figure 28. Global Medical Alpha Radionuclide Production Value Market Share by Region: 2021 vs 2025 vs 2032
 Figure 29. Global Medical Alpha Radionuclide Production Comparison by Region: 2021 vs 2025 vs 2032 (kg)
 Figure 30. Global Medical Alpha Radionuclide Production Market Share by Region: 2021 vs 2025 vs 2032
 Figure 31. North America Medical Alpha Radionuclide Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 32. Europe Medical Alpha Radionuclide Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 33. China Medical Alpha Radionuclide Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 34. Japan Medical Alpha Radionuclide Production Value (US$ Million) Growth Rate (2021–2032)
 Figure 35. Global Medical Alpha Radionuclide Consumption by Region: 2021 vs 2025 vs 2032 (kg)
 Figure 36. Global Medical Alpha Radionuclide Consumption Market Share by Region: 2021 vs 2025 vs 2032
 Figure 37. North America Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 38. North America Medical Alpha Radionuclide Consumption Market Share by Country (2021–2032)
 Figure 39. U.S. Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 40. Canada Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 41. Europe Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 42. Europe Medical Alpha Radionuclide Consumption Market Share by Country (2021–2032)
 Figure 43. Germany Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 44. France Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 45. U.K. Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 46. Italy Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 47. Russia Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 48. Asia Pacific Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 49. Asia Pacific Medical Alpha Radionuclide Consumption Market Share by Region (2021–2032)
 Figure 50. China Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 51. Japan Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 52. South Korea Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 53. China Taiwan Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 54. Southeast Asia Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 55. India Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 56. Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 57. Latin America, Middle East & Africa Medical Alpha Radionuclide Consumption Market Share by Country (2021–2032)
 Figure 58. Mexico Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 59. Brazil Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 60. Turkey Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 61. GCC Countries Medical Alpha Radionuclide Consumption and Growth Rate (kg), 2021–2032
 Figure 62. Global Production Market Share of Medical Alpha Radionuclide by Type (2021–2032)
 Figure 63. Global Production Value Market Share of Medical Alpha Radionuclide by Type (2021–2032)
 Figure 64. Global Medical Alpha Radionuclide Price (US$/g) by Type (2021–2032)
 Figure 65. Global Production Market Share of Medical Alpha Radionuclide by Application (2021–2032)
 Figure 66. Global Production Value Market Share of Medical Alpha Radionuclide by Application (2021–2032)
 Figure 67. Global Medical Alpha Radionuclide Price (US$/g) by Application (2021–2032)
 Figure 68. Medical Alpha Radionuclide Value Chain
 Figure 69. Channels of Distribution (Direct Vs Distribution)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure